VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ZCMDZhongchao Inc.
$0.65$67533
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksZCMDP/E History

ZCMD logoZhongchao Inc. (ZCMD) P/E Ratio History

Deep Value

Trading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2020–2022

Current P/E (TTM)
-0.0x
-100% vs 5Y avg
5Y Avg P/E
32.1x
Median 14.6x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-0.0x
Min9.7xMedian14.6xMax99.0x
TTM EPS$-62.18
Price$0.65
Earnings YieldN/A
EPS Growth (1Y)-92.7%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Zhongchao Inc. (ZCMD) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.65 and trailing twelve-month earnings per share of $-62.18.

The current P/E is 100% below its 5-year average of 32.1x. Over the past five years, ZCMD's P/E has ranged from a low of 9.7x to a high of 99.0x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, ZCMD trades at a 100% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, ZCMD trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZCMD DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ZCMD Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.0vs22.1
-100%
Below Sector
vs. S&P 500
-0.0vs24.4
-100%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -93% EPS growth (1Y)

ZCMD P/E vs Peers

Healthcare Communications, Workforce and Supply Chain peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
DOCS logoDOCSDoximity, Inc.
$4B20.9Lowest0.40Best-12%
VEEV logoVEEVVeeva Systems Inc.
$25B28.21.55+26%Best
HIMS logoHIMSHims & Hers Health, Inc.
$8B69.5--4%
IQV logoIQVIQVIA Holdings Inc.
$28B21.40.53+5%
PINC logoPINCPremier, Inc.
$2B128.5--79%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

ZCMD Historical P/E Data (2020–2022)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2022 Q2-$3213.77$32.4599.0x+208%
FY2021 Q4Dec 31 2021$4414.40$169.8426.0x-19%
FY2021 Q2Jun 30 2021$4563.20$469.929.7x-70%
FY2020 Q4-$4216.00$371.4111.4x-65%
FY2020 Q2-$5406.40$371.3714.6x-55%

Average P/E for displayed period: 32.1x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

6+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ZCMD — Frequently Asked Questions

Quick answers to the most common questions about buying ZCMD stock.

What is ZCMD's P/E ratio?

Zhongchao Inc. (ZCMD) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-62.18. The 5-year average P/E is 32.1x and the historical range spans 9.7x to 99.0x.

Is ZCMD stock overvalued or undervalued?

ZCMD current P/E: -0.0x. 5-year average P/E: 32.1x. Percentile: 0th.

Is ZCMD stock expensive?

ZCMD is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 32.1x (0th percentile of historical range).

What is ZCMD's historical P/E range?

Over the past 5 years, ZCMD's P/E ratio has ranged from 9.7x to 99.0x, with a median of 14.6x and an average of 32.1x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2020–2022.

How does ZCMD's P/E compare to the S&P 500?

ZCMD current P/E: -0.0x. S&P 500 median P/E: 24.4x.

How does ZCMD's valuation compare to Healthcare peers?

Zhongchao Inc. P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.

What is ZCMD's PEG ratio?

ZCMD PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of -92.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is ZCMD's earnings yield?

ZCMD earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

ZCMD P/E Ratio History (2020–2022)

Quarterly valuation multiple from closing price and trailing EPS

Current99.0x
Period Avg32.1x
Range9.7x - 99.0x
Change+580%
5 quartersJun 30, 2020 - Jun 30, 2022